SRC and cancer: Evaluation of cancer-related c-terminal variants perturbing the palindromic phospho-motif provides evidence of the existence of a complex allosteric node at the c-terminus of c-Src controlling the crosstalk between substrate- and enzyme-acting kinases; and how perturbation of this allosteric phospho-switch drive c-Src dysfunction in cancer.